Search for: "Price v. Illinois" Results 581 - 600 of 1,036
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 May 2007, 10:40 am
Bayer Corp., 398 F.3d 640, 643 (7th Cir. 2005) (applying Illinois law); Thomas v. [read post]
3 Aug 2020, 10:40 am by Jeremy T. Rosenblum and James Kim
”  This attempt to dismiss pricing impacts as insignificant simply doesn’t hold water. [read post]
15 Apr 2011, 6:02 am by Bexis
App. 1980) (barring recovery of damages for personal injury under HRS chapter 480).Nuff said.IdahoWe see nothing.IllinoisOnly “actual economic damages” may be awarded under the Illinois statute. [read post]
24 May 2012, 6:51 am
The possibility of investing in FB's initial public offering, as in any other IPO, always bore the risk of buying an IPO at a price above its market price-that is the price it has in the publicly traded market. [read post]
22 Mar 2011, 4:21 pm by Marie Louise
: Board of Trustees of Leland Stanford Junior University v Roche Molecular Systems Inc (IPKat) US: That was unexpectedly…  well… expected: BPAI affirms Examiner’s obviousness rejection in Ex Parte Akio Ochiai concerning a health food product containing curcumin, scymnol and isoflavones (BT-IP Notes) US: VirginiaTech VERSUS series – Drug evaluation DVDs available (FDA Law Blog) Products Diovan HCT (Valsartan, Hydrochlorothiazide) – Germany:… [read post]
11 May 2011, 4:54 am by Marie Louise
ARUP: Genetic testing patents found to be anticipated and in violation of Lilly written description requirement (Holman’s Biotech IP Blog) (Patent Docs) (Patently-O) US: FDA gets the ball rolling on biosimilar/interchangeable biological product user fee program; proposal gives a hat tip to PDUFA while acknowledging the nascent state of the industry (FDA Law Blog) (Patent Docs) Products Citalopram – UK Patents Court disapproving of EPO’s approach to assessment of novelty: Lundbeck… [read post]
23 Dec 2009, 5:28 am by Susan Brenner
Illinois, 359 U.S. 121, 123-124 (1959), the U.S. [read post]